Global Veterinary Molecular Diagnostics Market expected high growth opportunities by 2028
Overview of the Global Veterinary Molecular Diagnostics Market
Higher demand for animal-derived food, increased pet insurance demand, and increased animal health spending are driving the Veterinary Molecular Diagnostics Market. The rise in animal molecular diagnostics acceptance accounts for high specificity and efficiency in a short period of time, as well as the expansion of the Veterinary Molecular Diagnostics Market.
The market is expected to increase further because of the high prevalence of infectious diseases in animals, quick FDA approvals for reagents used in molecular diagnosis, and strong distribution channels.
Animal healthcare awareness is lacking in rising countries such as India, Brazil, and China, as well as a few Southeast Asian countries. Although the pet insurance market is growing, the number of animals covered for treatment remains low.
Definition of the Global Veterinary Molecular Diagnostics Market
Molecular diagnostics is the assessment of a wide spectrum of animal infections using molecular techniques. Traditional, real-time, and quantitative PCR techniques are used in molecular diagnosis.
These sophisticated approaches aid in the diagnosis of infectious diseases by detecting macromolecules quickly and accurately.
Veterinary molecular diagnosis has a number of advantages over traditional methods, including a shorter testing time, better separation between virulent and non-virulent strains, and excellent specificity and sensitivity.
This report includes market status and forecast of global and major regions, with the introduction of vendors, regions, product types, and end industries; and this report counts product types and end industries in global and major regions.
Some of the Major Market Key Players –
- IDEXX Laboratories, Inc.
- ABAXIS, Inc.
- VCA, Inc.
- Neogen Corporation
- Thermo Fisher Scientific, Inc.
- Zoetis, Inc.
- GE Healthcare
- Heska Corporation
- ID.Vet, Virbac,
- Veterinary Molecular Diagnostics, Inc.
- AGFA Healthcare.
Zion Market Research has split the worldwide veterinary diagnostics market research by product, species, illness type, testing type, end-use, and region for this study:
Browse Press Release @ https://www.zionmarketresearch.com/news/veterinary-molecular-diagnostics-market
Key Market Segmentation:
By Product Segment Analysis
- Instruments & Software
- Kits & Reagents
- Services
By Technology Segment Analysis
- Polymerase Chain Reaction (PCR)
- Microarrays
- DNA Sequencing
By Animal Type Segment Analysis
- Companion Animals
- Livestock Animals
by Disease Indication Segment Analysis
- Vector-borne Diseases
- Respiratory Pathogens Detection
- Diarrhea Pathogens Detection
- Others
By End-User Segment Analysis
- Veterinary Hospitals
- Clinical Laboratories
- Research Institutes
By Regional Segment Analysis
- North America: U.S, Canada, Mexico
- South America: Brazil, Argentina, Colombia
- Europe: U.K, Germany, Italy, France, Poland, Belgium, Spain, Russia
- APAC: China, Australia, South Korea, India, Japan
- Rest of the World: Middle East, Africa
The emergence of middle-class households, higher disposable income, acceptance of pet animals, and a high need for animal proteins are all predicted to fuel regional market growth.
The Impact of the COVID-19 Crisis on the Veterinary Molecular Diagnostics Market
The COVID19 pandemic has had a significant impact on most markets. The virus is spreading rapidly over the world, causing huge disruptions in important activities in every country. The impact is negative and strong enough to have caused the market’s expansion to slow.
In 2021, the immunodiagnostics segment ruled the veterinary diagnostics market.
The development of improved diagnostic immunoassay tests and the increased acceptance of diagnostic goods based on immunodiagnostic technology are both contributing to the immunodiagnostics segment’s growth. Furthermore, veterinary practitioners prefer immunodiagnostics tests due to their high accuracy standards, increasing use of miniaturized devices, and the rising trend of automation in immunoassay instruments are all contributing to the segment’s greatest share.
